This test is most useful if any of these apply to you.
Benzene is one of the most studied human carcinogens, and most of us absorb at least some of it without realizing. It comes from cigarette smoke, gasoline fumes, vehicle exhaust, paints, glues, and many industrial processes. The trouble with benzene is that you cannot feel it entering your body, and it leaves your bloodstream within hours. What you can measure is the trail it leaves behind.
NAP (N-acetyl phenyl cysteine), also called S-phenylmercapturic acid, is that trail. When benzene reaches your liver, your detox enzymes attach it to a small protector molecule called glutathione, then trim and modify it until it ends up in your urine as NAP. Measuring NAP gives you a window into how much benzene you actually absorbed in the past day or two, regardless of where it came from.
This test quantifies NAP in a urine sample, typically reported in micrograms per gram of creatinine (a normalization step that adjusts for how concentrated or dilute your urine is). NAP is a specific metabolite of benzene, not a general marker of pollution or cellular damage. A higher NAP level means more benzene reached your tissues recently. A lower level means less. Because benzene clears your body within hours and NAP is excreted shortly after, the test reflects exposure in roughly the past 24 to 48 hours rather than long-term cumulative dose.
This is a research-grade biomarker. It is well-validated for occupational exposure monitoring, where it is used by industrial hygienists to check whether workers are absorbing benzene above safety limits. Its use as a general consumer health marker is newer, and standardized clinical decision thresholds for individual risk prediction do not yet exist.
Benzene is classified as a known human carcinogen, with the strongest established link to leukemia and other blood cancers. The case for testing your benzene burden does not rest on NAP studies alone, because most large outcome research has measured other VOC metabolites. What NAP specifically tells you is whether benzene is reaching your body in meaningful amounts, which is the upstream step that drives risk.
Studies measuring related urinary VOC metabolites (chemicals from the same broader family of toxins, but not NAP specifically) have found patterns worth noting. In a cross-sectional analysis of 5,211 U.S. adults, a combined index of 19 urinary mercapturic acid metabolites was associated with about 20% higher odds of having had a heart attack per unit increase in the combined exposure score. PHEMA, a related mercapturic acid from styrene rather than benzene, was among the metabolites most associated with heart attack risk in that analysis. These findings come from related-but-different molecules, and they are observational and cross-sectional, so they cannot prove that benzene exposure alone causes heart disease. They do suggest that the broader category of VOC absorption is worth tracking.
Separately, in a study of 4,156 adults, higher urinary levels of certain VOC metabolites were associated with higher hypertension risk. Older adults in NHANES with higher VOC exposure also showed altered glucose handling and elevated odds of type 2 diabetes. None of these studies isolated NAP as the driver, but they form part of the case that low-level VOC absorption is not biologically inert.
Cigarette smoke is the dominant source of benzene exposure for most non-occupationally exposed adults. Smokers have substantially higher urinary mercapturic acids than non-smokers across multiple biomonitoring studies. This is the most actionable insight a NAP test can offer for the average person: if you smoke or live with someone who does, your number will be visibly higher than someone in a clean-air environment, and quitting will pull it down.
NAP is the standard biomarker used in workplace surveillance for benzene-exposed industries: petrochemicals, refining, coke production, rubber manufacturing, paint and adhesives, and gasoline distribution. In a study of 98 coke oven workers, urinary mercapturic acid levels were 2 to 10 times higher than in nearby residents, with workplace exposures landing within 20% of the official biological limit values. If you work in any industry where benzene, gasoline, or solvent vapors are present, NAP is the most direct way to see whether your protective equipment and ventilation are actually keeping the chemical out of you.
There are no consensus clinical cutpoints for NAP in the general public. The values below are research-derived orientation only, drawn from occupational biomonitoring literature where reference values vary by laboratory and method. Different labs using different testing methods can produce results that differ by 60% or more on the same sample. Compare your results within the same lab over time.
| Tier | Approximate Range | What It Suggests |
|---|---|---|
| Background (non-smoker, low exposure) | Low end of detection | Typical of adults in clean-air environments without occupational exposure |
| Elevated (smoker or environmental exposure) | Several-fold higher than non-smokers | Consistent with active tobacco use or living/working near significant benzene sources |
| Occupational range | Up to 10x higher than background | Seen in workers in petrochemical, coke oven, refining, and similar industries |
What this means for you: rather than fixating on a single threshold, watch how your number compares to your own past results and to expected ranges for your situation. A non-smoker with no industrial exposure should see a low NAP value. A higher-than-expected value warrants asking where the benzene is coming from.
Because benzene exposure varies day to day with what you breathe, where you commute, and what you do, a single NAP measurement is a snapshot of one short window. The real value comes from serial testing. Get a baseline. If it is elevated, change something specific (quit smoking, switch your commute, improve ventilation in a workshop, change jobs) and retest in 4 to 8 weeks. The half-life of NAP is short enough that a sustained reduction in exposure should show up quickly.
For most adults without known occupational exposure, an annual check-in is reasonable, with more frequent retesting (every 3 to 6 months) when you are actively trying to lower the number. For workers in benzene-exposed industries, follow whatever schedule your occupational health program uses, which is typically more frequent.
If your NAP is higher than expected for your situation, the next step is to find the source rather than to repeat the test endlessly. Walk through your daily life: do you smoke or vape, are you regularly exposed to secondhand smoke, do you commute through heavy traffic with windows down, do you pump your own gas frequently, do you work with solvents or paints, do you live near a refinery or major roadway. If a clear source is identified, address it and retest. If no obvious source is apparent and the value remains elevated on a repeat test, ordering a broader urinary toxin panel and discussing the result with a physician familiar with environmental medicine or occupational health can help. NAP itself is not a diagnostic test for any specific disease; an elevated value is a flag to investigate exposure, not a finding that requires medical treatment.
Evidence-backed interventions that affect your NAP level
N-Acetyl Phenyl Cysteine is best interpreted alongside these tests.